Marked decrease of plasma neuroactive steroids during alcohol withdrawal

E. Romeo, A. Brancati, A. De Lorenzo, P. Fucci, C. Furnari, E. Pompili, G. F. Sasso, G. Spalletta, A. Troisi, A. Pasini

Research output: Contribution to journalArticle

Abstract

The neuroactive steroids allopregnanolone (ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are the most potent endogenous positive modulators of γ-aminobutyric acid (GABA) on GABA(A) receptors, a receptor system presumably responsible for some behavioral responses to alcohol withdrawal. In a group of nine alcoholic subjects, the levels of plasma ALLO and THDOC were markedly lower than those of control subjects during the early withdrawal phase (day 4 and 5), when anxiety and depression scores were higher. In contrast ALLO and THDOC plasma levels did not differ from those of control subjects during the late withdrawal phase when anxiety and depression scores were low. These results suggest that the decrease of neuroactive steroid biosynthesis may contribute to the withdrawal symptoms.

Original languageEnglish
Pages (from-to)366-369
Number of pages4
JournalClinical Neuropharmacology
Volume19
Issue number4
Publication statusPublished - 1996

Fingerprint

Pregnanolone
Steroids
Alcohols
Anxiety
Depression
Aminobutyrates
Substance Withdrawal Syndrome
GABA-A Receptors
Alcoholics
gamma-Aminobutyric Acid
tetrahydrodeoxycorticosterone

Keywords

  • Alcohol
  • Anxiety
  • Depression
  • Steroids
  • Withdrawal

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Romeo, E., Brancati, A., De Lorenzo, A., Fucci, P., Furnari, C., Pompili, E., ... Pasini, A. (1996). Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clinical Neuropharmacology, 19(4), 366-369.

Marked decrease of plasma neuroactive steroids during alcohol withdrawal. / Romeo, E.; Brancati, A.; De Lorenzo, A.; Fucci, P.; Furnari, C.; Pompili, E.; Sasso, G. F.; Spalletta, G.; Troisi, A.; Pasini, A.

In: Clinical Neuropharmacology, Vol. 19, No. 4, 1996, p. 366-369.

Research output: Contribution to journalArticle

Romeo, E, Brancati, A, De Lorenzo, A, Fucci, P, Furnari, C, Pompili, E, Sasso, GF, Spalletta, G, Troisi, A & Pasini, A 1996, 'Marked decrease of plasma neuroactive steroids during alcohol withdrawal', Clinical Neuropharmacology, vol. 19, no. 4, pp. 366-369.
Romeo E, Brancati A, De Lorenzo A, Fucci P, Furnari C, Pompili E et al. Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clinical Neuropharmacology. 1996;19(4):366-369.
Romeo, E. ; Brancati, A. ; De Lorenzo, A. ; Fucci, P. ; Furnari, C. ; Pompili, E. ; Sasso, G. F. ; Spalletta, G. ; Troisi, A. ; Pasini, A. / Marked decrease of plasma neuroactive steroids during alcohol withdrawal. In: Clinical Neuropharmacology. 1996 ; Vol. 19, No. 4. pp. 366-369.
@article{e11e8cc102e44a07810f31df435921f6,
title = "Marked decrease of plasma neuroactive steroids during alcohol withdrawal",
abstract = "The neuroactive steroids allopregnanolone (ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are the most potent endogenous positive modulators of γ-aminobutyric acid (GABA) on GABA(A) receptors, a receptor system presumably responsible for some behavioral responses to alcohol withdrawal. In a group of nine alcoholic subjects, the levels of plasma ALLO and THDOC were markedly lower than those of control subjects during the early withdrawal phase (day 4 and 5), when anxiety and depression scores were higher. In contrast ALLO and THDOC plasma levels did not differ from those of control subjects during the late withdrawal phase when anxiety and depression scores were low. These results suggest that the decrease of neuroactive steroid biosynthesis may contribute to the withdrawal symptoms.",
keywords = "Alcohol, Anxiety, Depression, Steroids, Withdrawal",
author = "E. Romeo and A. Brancati and {De Lorenzo}, A. and P. Fucci and C. Furnari and E. Pompili and Sasso, {G. F.} and G. Spalletta and A. Troisi and A. Pasini",
year = "1996",
language = "English",
volume = "19",
pages = "366--369",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Marked decrease of plasma neuroactive steroids during alcohol withdrawal

AU - Romeo, E.

AU - Brancati, A.

AU - De Lorenzo, A.

AU - Fucci, P.

AU - Furnari, C.

AU - Pompili, E.

AU - Sasso, G. F.

AU - Spalletta, G.

AU - Troisi, A.

AU - Pasini, A.

PY - 1996

Y1 - 1996

N2 - The neuroactive steroids allopregnanolone (ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are the most potent endogenous positive modulators of γ-aminobutyric acid (GABA) on GABA(A) receptors, a receptor system presumably responsible for some behavioral responses to alcohol withdrawal. In a group of nine alcoholic subjects, the levels of plasma ALLO and THDOC were markedly lower than those of control subjects during the early withdrawal phase (day 4 and 5), when anxiety and depression scores were higher. In contrast ALLO and THDOC plasma levels did not differ from those of control subjects during the late withdrawal phase when anxiety and depression scores were low. These results suggest that the decrease of neuroactive steroid biosynthesis may contribute to the withdrawal symptoms.

AB - The neuroactive steroids allopregnanolone (ALLO) and allotetrahydrodeoxycorticosterone (THDOC) are the most potent endogenous positive modulators of γ-aminobutyric acid (GABA) on GABA(A) receptors, a receptor system presumably responsible for some behavioral responses to alcohol withdrawal. In a group of nine alcoholic subjects, the levels of plasma ALLO and THDOC were markedly lower than those of control subjects during the early withdrawal phase (day 4 and 5), when anxiety and depression scores were higher. In contrast ALLO and THDOC plasma levels did not differ from those of control subjects during the late withdrawal phase when anxiety and depression scores were low. These results suggest that the decrease of neuroactive steroid biosynthesis may contribute to the withdrawal symptoms.

KW - Alcohol

KW - Anxiety

KW - Depression

KW - Steroids

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=9344232788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344232788&partnerID=8YFLogxK

M3 - Article

C2 - 8829001

AN - SCOPUS:9344232788

VL - 19

SP - 366

EP - 369

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 4

ER -